<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Magnetic resonance imaging of the thorax</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Magnetic resonance imaging of the thorax</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Magnetic resonance imaging of the thorax</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel Chernoff, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Stark, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Magnetic resonance imaging (MRI) is an important tool in assessment of diseases of the heart, mediastinum, pleura, and chest wall [<a href="#rid1">1,2</a>]. Strengths of MRI include excellent tissue contrast, multiplanar imaging capability, sensitivity to blood flow, and lack of ionizing radiation. The lack of ionizing radiation make MR an excellent imaging choice for pediatric examinations, pregnant women and patients requiring serial and longitudinal follow-up [<a href="#rid3">3</a>]. Application of MRI in intrinsic lung disease has been limited by signal loss from physiologic lung motion, low signal intensity due to paucity of protons, and magnetic field inhomogeneities induced by the air/tissue interfaces in lung, problems that may be overcome with improvements in imaging hardware and pulse sequences, like ultrashort echo time or zero echo time, multicoil parallel acquisitions and acceleration methods [<a href="#rid3">3,4</a>]. Prospective studies have shown that nonvascular thoracic MR has the potential to reduce the number of planned surgical interventions, modify the surgical approach, increase surgeon comfort with the patient management plan, increase diagnostic certainty, and avoid unnecessary follow-up or clinical care [<a href="#rid5">5</a>]. The noncardiac clinical indications for thoracic MRI will be presented here; technical aspects of thoracic and cardiac MRI are reviewed separately. (See  <a class="medical medical_review" href="/d/html/5309.html" rel="external">"Principles of magnetic resonance imaging"</a> and  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL INDICATIONS</span></p><p class="headingAnchor" id="H3"><span class="h2">Chest wall and diaphragm</span><span class="headingEndMark"> — </span>MRI is an excellent imaging modality for assessment of primary chest wall tumors [<a href="#rid6">6</a>], chest wall phlegmons or abscesses, and chest wall or diaphragmatic extension of intrathoracic masses. On T1-weighted images, particularly with contrast material enhancement, the extent of invasion of normal tissues can usually be established  (<a class="graphic graphic_diagnosticimage graphicRef74264 graphicRef53251 graphicRef65039" href="/d/graphic/74264.html" rel="external">image 1A-C</a> and <a class="graphic graphic_diagnosticimage graphicRef78372 graphicRef56298 graphicRef64987 graphicRef75753" href="/d/graphic/78372.html" rel="external">image 2A-D</a> and <a class="graphic graphic_diagnosticimage graphicRef61630 graphicRef67306" href="/d/graphic/61630.html" rel="external">image 3A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef66436 graphicRef78690 graphicRef59287" href="/d/graphic/66436.html" rel="external">image 4A-C</a>) [<a href="#rid7">7-10</a>]. (See  <a class="medical medical_review" href="/d/html/5309.html" rel="external">"Principles of magnetic resonance imaging"</a>.)</p><p>Vascular encasement or invasion is frequently well visualized on T1-weighted images. GRE (bright blood) sequences can sometimes demonstrate vascular invasion more clearly, and can regularly demonstrate the vascular supply of tumors. T2-weighted sequences play a secondary role in evaluation of the chest wall. Their primary use is in demonstrating areas of cystic degeneration, inflammation, and edema.</p><p>The ability of MRI to display arbitrary planes of section used to be an advantage over computed tomography (CT) in assessment of the lung apices, diaphragm, and spinal column. However, the newer generation of multislice CT scanners, by enabling rapid near-isotropic imaging of the entire thorax at submillimeter resolution, has considerably narrowed this advantage. The ability to manipulate the relative signal intensities of normal and abnormal tissue through appropriate use of MRI pulse sequences remains a relative advantage of MRI over CT and achieves superior contrast resolution and more accurate tissue characterization. Although cortical bone destruction is better demonstrated by CT, bone marrow involvement by tumor is better visualized on MRI.</p><p class="headingAnchor" id="H4"><span class="h2">Pleura</span><span class="headingEndMark"> — </span>MRI is comparable to CT in evaluating pleural disease [<a href="#rid11">11-13</a>]. MRI may also be better at demonstrating extension of pleural lesions into the chest wall, mediastinum, and diaphragm. Imaging in sagittal and coronal planes is especially helpful in assessing the extent of malignant tumors, such as mesothelioma  (<a class="graphic graphic_diagnosticimage graphicRef66436 graphicRef78690 graphicRef59287" href="/d/graphic/66436.html" rel="external">image 4A-C</a>) [<a href="#rid14">14-16</a>]. MRI can potentially characterize pleural effusions, and differentiate between exudates, transudates, and hemothoraces [<a href="#rid17">17</a>]. Chylous pleural effusions can be assessed with MRI multipoint Dixon fat quantification [<a href="#rid18">18</a>]. However, CT remains advantageous for visualizing calcification within pleural lesions and displaying the "split pleura sign" seen in exudative pleural effusions or empyemas [<a href="#rid13">13</a>]. Magnetic resonance imaging has proved advantageous in elucidating the source of a chylothorax by analyzing the morphology of the thoracic duct and detecting accessory lymphatic channels in patients with chylous pleural effusions [<a href="#rid19">19</a>]. Nonenhanced MR lymphography has proven advantageous: it is a noninvasive technique based on heavily T2-weighted sequences, enabling the display of the lymphatic circulation [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Paraspinal masses</span><span class="headingEndMark"> — </span>MRI is well suited for evaluation of paraspinal masses because of its multiplanar imaging capability. It can clearly demonstrate the craniocaudal extent of disease, involvement of the spinal column, and/or extension into the spinal canal  (<a class="graphic graphic_diagnosticimage graphicRef69331 graphicRef76000" href="/d/graphic/69331.html" rel="external">image 5A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef132315" href="/d/graphic/132315.html" rel="external">image 6</a> and <a class="graphic graphic_diagnosticimage graphicRef132314" href="/d/graphic/132314.html" rel="external">image 7</a>). CT evaluation of intraspinal extent of paraspinal masses can suffer from beam-hardening artifact produced by the high attenuation spinal column; MRI has no similar limitation. Paraspinal schwannomas display a target appearance with high signal in the periphery and lower signal centrally. In rare instances, paraspinal desmoid tumors can be encountered and mimic ganglioneuromas.</p><p class="headingAnchor" id="H6"><span class="h2">Mediastinum and hila</span><span class="headingEndMark"> — </span>MRI is useful in evaluating mediastinal and hilar disease, though it cannot match the superior spatial resolution of CT  (<a class="graphic graphic_diagnosticimage graphicRef63277 graphicRef75079" href="/d/graphic/63277.html" rel="external">image 8A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef78631 graphicRef56669" href="/d/graphic/78631.html" rel="external">image 9A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef59535" href="/d/graphic/59535.html" rel="external">image 10</a> and <a class="graphic graphic_diagnosticimage graphicRef132316" href="/d/graphic/132316.html" rel="external">image 11</a>) [<a href="#rid21">21,22</a>]. An advantage of MRI includes its multiplanar capability, which enhances:</p><p class="bulletIndent1"><span class="glyph">●</span>Mediastinal tumor staging. Coronal and sagittal sections reliably detect subcarinal and aorticopulmonary lymph node masses.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of local tumor extension. Lack of signal from flowing blood in spin echo images permits distinction of solid tissue (such as lymph nodes) from blood vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tissue characterization. Double inversion recovery T2 spin echo sequences allows for the diagnosis of thymic cysts and bronchogenic cysts with high attenuation on CT scanning. Low T2 signal due to fibrous tissue results in “dark lymph nodes”; it facilitates the diagnosis of treated lymphoma, sarcoidosis, or sclerosing mediastinitis. Chemical-shift MRI can be useful in the diagnosis of thymic hyperplasia, dermoid cysts, and hamartomas (all these lesions contain microscopic fatty tissue with loss of signal on double echo, opposed phase gradient echo imaging) [<a href="#rid23">23</a>]. Iron deposition in tissue can be identified with loss of signal on double echo, in-phase imaging due to the T2 star effect, eg, in sickle cell disease or after multiple blood transfusions [<a href="#rid24">24</a>].</p><p></p><p>The use of MRI in lymphoma staging is well established [<a href="#rid25">25,26</a>], although the generally greater spatial resolution of CT makes it superior to MRI for this indication [<a href="#rid26">26</a>]. MRI can also be valuable in lesion characterization, as with distinguishing hematoma or fibrosis from neoplasm.</p><p>Diffusion-weighted MR imaging has been utilized in characterizing and staging thymic epithelial tumors [<a href="#rid27">27</a>]. </p><p>Both MRI and CT have been partially supplanted by positron emission tomography (PET) with fluorodeoxyglucose (FDG) in mediastinal tumor staging [<a href="#rid28">28</a>]. Unlike MRI and CT, which are primarily anatomic imaging techniques, FDG-PET can identify malignant tumors based on their high glucose utilization and metabolic characteristics, in addition to their appearance. Integrated PET-CT scanners provide additional advantages by combining functional information from PET with anatomic information from CT in a single examination. PET/MR imaging has been introduced for use in patients and may have diagnostic performance comparable to PET/CT [<a href="#rid29">29</a>], but PET/MRI is not widely available.</p><p>Short inversion time, inversion-recovery, fast spin-echo MRI and diffusion-weighted MRI show future potential and may even have greater sensitivity and accuracy in evaluating lymph node involvement in non-small cell carcinoma of the lungs [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Lung parenchyma</span><span class="headingEndMark"> — </span>MRI currently plays only a limited role in evaluation of the lung  (<a class="graphic graphic_diagnosticimage graphicRef116879" href="/d/graphic/116879.html" rel="external">image 12</a>). This is the result of many factors, including poorer spatial resolution than CT, low proton density, long imaging times compared with CT causing physiologic motion artifact, and magnetic susceptibility-induced signal loss at the border between the alveolar wall and alveolar gas. In interstitial lung disease, MRI may find a niche in distinguishing active disease (high signal on T2-weighted images) from inactive disease/fibrosis (low T2 signal intensity) [<a href="#rid30">30</a>].</p><p>Novel lung techniques are being investigated [<a href="#rid31">31</a>]. Ultrashort echo time and zero echo time MR imaging have been used to image the lung parenchyma [<a href="#rid3">3,32</a>] and to quantify emphysema severity [<a href="#rid33">33</a>]. Elastic registration during inspiration and expiration with quantification of voxel deformity can be used to facilitate early diagnosis of pulmonary fibrosis [<a href="#rid34">34</a>].</p><p>Imaging of inhaled hyperpolarized helium or xenon is being studied as a way to determine the apparent diffusion coefficient of helium or xenon and regional lung ventilation [<a href="#rid35">35-38</a>]. For instance, exercise-induced bronchoconstriction can be evaluated reproducibly with hyperpolarized HE3 MRI or <a class="drug drug_general" data-topicid="140393" href="/d/drug information/140393.html" rel="external">hyperpolarized Xenon 129</a> imaging [<a href="#rid3">3,39</a>]. Blood tagging techniques with gadolinium or arterial spin labeling are being studied as a way to evaluate regional lung perfusion and in specialized centers, high-altitude pulmonary edema [<a href="#rid40">40</a>]. Assessment of lung morphology with balanced steady-state free precession MR imaging has been shown to be inferior to CT in imaging lung parenchymal disease, yet it represents an alternative radiation-free imaging modality in patients with pulmonary fibrosis [<a href="#rid41">41</a>]. These techniques are not widely available in clinical practice at this time. Simultaneous imaging of lung structure and function with triple-nuclear hybrid MR imaging has been demonstrated in a research setting, utilizing single breath hold technique with two hyperpolarized gasses, Helium and Xenon 129 with simultaneous registered anatomic proton MR images of lung structure [<a href="#rid42">42</a>].</p><p>Evaluation of cystic fibrosis with proton MRI has been introduced in selected centers for routine clinical management and long-term monitoring of these patients. Proton MRI provides morphologic information concerning mucus distribution, bronchiectasis, inflammatory airways wall thickening, consolidation and atelectasis of lung parenchyma [<a href="#rid3">3,43,44</a>]. Air-trapping and perfusion abnormalities due to hypoxic vasoconstriction (von Euler-Liljestrand reflex) can be revealed with three-dimensional gradient-echo imaging, balanced steady-state free precession, arterial spin-labeling and hyperpolarized gases [<a href="#rid3">3</a>]. Allergic bronchopulmonary aspergillosis in cystic fibrosis can be imaged with T1-and T2-weighted spin-echo sequences; mucoid impaction with T1 high signal and T2 low signal can lead to inversion of the expected signal owing to an increase in calcium salts, iron or manganese contents. This inverted mucoid impaction signal can help in the diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis with bronchiectases [<a href="#rid45">45</a>].</p><p>In patients with chronic obstructive pulmonary disease (COPD), traditional gas-based ventilation imaging methods with Helium-3 or <a class="drug drug_general" data-topicid="140393" href="/d/drug information/140393.html" rel="external">hyperpolarized Xenon 129</a> could be replaced in the future with two-dimensional or three-dimensional proton-based regional ventilation MRI techniques [<a href="#rid46">46,47</a>].</p><p class="headingAnchor" id="H3255001662"><span class="h2">Lung cancer screening</span><span class="headingEndMark"> — </span>CT is well-established as a screening tool for early detection of lung carcinoma in high-risk patients, now endorsed by the US Preventive Services Task Force [<a href="#rid48">48</a>]. MRI is a potential alternative to CT for lung cancer screening, the primary advantage of which is absence of ionizing radiation. Many technical challenges to detection of small pulmonary nodules by MRI persist, including lower spatial resolution compared with CT, breathing and cardiac motion artifacts, and magnetic susceptibility artifacts. However, many of these limitations are yielding to hardware and pulse sequence improvements, such that lung cancer screening by MRI is now feasible, although not widely available [<a href="#rid49">49</a>]. In particular, imaging at higher field strength and using ultrashort echo times has been shown to increase MRI sensitivity for lung nodule detection [<a href="#rid50">50</a>].  </p><p class="headingAnchor" id="H8"><span class="h2">Bronchogenic carcinoma</span><span class="headingEndMark"> — </span>MRI is comparable to CT in staging lung cancer complicated by chest wall, diaphragm, pleura, or mediastinal involvement  (<a class="graphic graphic_diagnosticimage graphicRef74264 graphicRef53251 graphicRef65039" href="/d/graphic/74264.html" rel="external">image 1A-C</a> and <a class="graphic graphic_diagnosticimage graphicRef78372 graphicRef56298 graphicRef64987 graphicRef75753" href="/d/graphic/78372.html" rel="external">image 2A-D</a> and <a class="graphic graphic_diagnosticimage graphicRef61630 graphicRef67306" href="/d/graphic/61630.html" rel="external">image 3A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef78631 graphicRef56669" href="/d/graphic/78631.html" rel="external">image 9A-B</a>) [<a href="#rid29">29,51-54</a>]. MRI may have greater specificity in the diagnosis of adrenal masses found on staging examinations in patients with lung cancer. However, MRI currently plays only an adjunctive role to CT for staging of lung cancer, because of higher cost, poorer spatial resolution, longer examination duration, less availability, and because CT can diagnose and stage lung cancer in a single examination. The use of MRI is reserved for those cases in which the tumor is suspected to be unresectable, but CT findings are not definitive (as in Pancoast [superior sulcus] tumors) [<a href="#rid55">55,56</a>] or cases in which the patient has a history of reaction to iodinated contrast agents (see  <a class="medical medical_review" href="/d/html/4605.html" rel="external">"Superior pulmonary sulcus (Pancoast) tumors"</a>). Whole-body hybrid PET/MR imaging may play a future role in staging of bronchogenic carcinoma [<a href="#rid57">57,58</a>] and in characterizing pulmonary nodules [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Aortic disease</span><span class="headingEndMark"> — </span>MRI is an excellent imaging tool for the diagnosis of aneurysm and aortic dissection. Spin echo sequences and other "black blood" techniques, can detect the medio-intimal flap and determine the type and extent of dissection. Gradient echo sequences can differentiate the true lumen (with higher flow and higher signal intensity) from the false lumen (with lower flow and lower signal intensity). Contrast material-enhanced MR angiography is widely used for evaluation of aortic disease as technical capabilities of scanners have improved. In the past, transesophageal echocardiography and MRI have been considered the two methods of choice for diagnosing dissections. However, advances in CT technology and the greater availability of multislice CT have caused this latter modality to assume a primary role in imaging of aortic disease. (See  <a class="medical medical_review" href="/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Pulmonary vascular disease</span><span class="headingEndMark"> — </span>Pulmonary artery dilation, a finding suggestive of pulmonary artery hypertension, can be imaged well by MRI [<a href="#rid60">60</a>]. MR angiography is able to detect vascular intraluminal filling defects (eg, emboli), but pulmonary emboli are currently better visualized using CT [<a href="#rid61">61,62</a>]. New MR sequences may further facilitate visualization of pulmonary emboli [<a href="#rid63">63</a>]. Dynamic contrast-enhanced lung perfusion MRI facilitates screening for chronic thromboembolic pulmonary hypertension [<a href="#rid3">3</a>]. The use of intravenous gadolinium-based contrast material (as a first pass perfusion agent) and arterial spin labeling (endogenous perfusion assessment without injection) may expand the role of MRI in the diagnosis of pulmonary vascular disease [<a href="#rid4">4,64-68</a>]. (See  <a class="medical medical_review" href="/d/html/8261.html" rel="external">"Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism"</a> and  <a class="medical medical_review" href="/d/html/8254.html" rel="external">"Epidemiology, pathogenesis, clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension"</a>.)</p><p>Future applications of MR in the chest include MR imaging evaluation of cardiovascular risk in metabolic syndrome and molecular body imaging as well as whole-body population-based MR imaging [<a href="#rid69">69,70</a>].</p><p>Functional, dynamic MR imaging of the chest is currently being studied in the evaluation of diaphragmatic motion [<a href="#rid23">23</a>], in the analysis of lung tidal volumes, and in the assessment of postoperative effects on the chest wall and diaphragm dynamics of breathing [<a href="#rid71">71</a>].</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for magnetic resonance imaging (MRI) of the chest</strong> - MRI is an important tool in the evaluation of chest structures. Although computed tomography (CT) plays a primary role in noncardiac chest imaging, the multiplanar capabilities and excellent tissue contrast resolution and tissue characterization of MRI make it equal or superior to CT in several areas including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of the lung apices, diaphragm, and spinal column</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of pleural disease</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of mediastinal cysts with high attenuation on CT scanning</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of paraspinal masses</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of local tumor extension, particularly chest wall invasion, and delineation of blood vessel invasion</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Metastatic invasion of bone marrow</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Certain aspects of staging of bronchogenic carcinoma; however, MRI still plays an adjunctive role to CT in this setting</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serial and long-term follow-up of patients with cystic fibrosis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications of CT chest</strong> - CT remains the preferred technique in the following settings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of lung parenchymal disease</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of mediastinal lymph nodes and lymphoma staging</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of cortical bone metastases</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Staging of bronchogenic carcinoma (in most cases)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aortic aneurysms and dissection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Detection of pulmonary embolism</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lung cancer screening</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology 2012; 264:349.</a></li><li><a class="nounderline abstract_t">Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. part I. principles. Radiology 2012; 263:633.</a></li><li><a class="nounderline abstract_t">Hatabu H, Stock KW, Sher S, et al. Magnetic resonance imaging of the thorax. Past, present, and future. Radiol Clin North Am 2000; 38:593.</a></li><li><a class="nounderline abstract_t">Vogt FM, Goyen M, Debatin JF. MR angiography of the chest. Radiol Clin North Am 2003; 41:29.</a></li><li><a class="nounderline abstract_t">Ackman JB, Gaissert HA, Lanuti M, et al. Impact of Nonvascular Thoracic MR Imaging on the Clinical Decision Making of Thoracic Surgeons: A 2-year Prospective Study. Radiology 2016; 280:464.</a></li><li><a class="nounderline abstract_t">Carter BW, Benveniste MF, Madan R, et al. IASLC/ITMIG Staging System and Lymph Node Map for Thymic Epithelial Neoplasms. Radiographics 2017; 37:758.</a></li><li><a class="nounderline abstract_t">Fortier M, Mayo JR, Swensen SJ, et al. MR imaging of chest wall lesions. Radiographics 1994; 14:597.</a></li><li><a class="nounderline abstract_t">Kuhlman JE, Bouchardy L, Fishman EK, Zerhouni EA. CT and MR imaging evaluation of chest wall disorders. Radiographics 1994; 14:571.</a></li><li><a class="nounderline abstract_t">Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993; 187:33.</a></li><li><a class="nounderline abstract_t">Hatabu H, Ohno Y, Gefter WB, et al. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper. Radiology 2020; 297:286.</a></li><li><a class="nounderline abstract_t">Schmutz GR, Fisch-Ponsot C, Regent D, Sylvestre J. Computed tomography (CT) and magnetic resonance imaging (MRI) of pleural masses. Crit Rev Diagn Imaging 1993; 34:309.</a></li><li><a class="nounderline abstract_t">McLoud TC. CT and MR in pleural disease. Clin Chest Med 1998; 19:261.</a></li><li><a class="nounderline abstract_t">Hierholzer J, Luo L, Bittner RC, et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118:604.</a></li><li><a class="nounderline abstract_t">Patz EF Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159:961.</a></li><li><a class="nounderline abstract_t">Heelan RT. CT and MR imaging in the evaluation of pleural masses. Chest Surg Clin N Am 1994; 4:431.</a></li><li><a class="nounderline abstract_t">Nickell LT Jr, Lichtenberger JP 3rd, Khorashadi L, et al. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics 2014; 34:1692.</a></li><li><a class="nounderline abstract_t">Davis SD, Henschke CI, Yankelevitz DF, et al. MR imaging of pleural effusions. J Comput Assist Tomogr 1990; 14:192.</a></li><li><a class="nounderline abstract_t">Kuetting D, Luetkens J, Fimmers R, et al. MRI Assessment of Chylous and Nonchylous Effusions: Use of Multipoint Dixon Fat Quantification. Radiology 2020; 296:698.</a></li><li><a class="nounderline abstract_t">Yu DX, Ma XX, Wang Q, et al. Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging. Eur Radiol 2013; 23:702.</a></li><li><a class="nounderline abstract_t">Cholet C, Delalandre C, Monnier-Cholley L, et al. Nontraumatic Chylothorax: Nonenhanced MR Lymphography. Radiographics 2020; 40:1554.</a></li><li><a class="nounderline abstract_t">Link KM, Samuels LJ, Reed JC, et al. Magnetic resonance imaging of the mediastinum. J Thorac Imaging 1993; 8:34.</a></li><li><a class="nounderline abstract_t">Grover FL. The role of CT and MRI in staging of the mediastinum. Chest 1994; 106:391S.</a></li><li><a class="nounderline abstract_t">Ackman JB. A practical guide to nonvascular thoracic magnetic resonance imaging. J Thorac Imaging 2014; 29:17.</a></li><li><a class="nounderline abstract_t">Labranche R, Gilbert G, Cerny M, et al. Liver Iron Quantification with MR Imaging: A Primer for Radiologists. Radiographics 2018; 38:392.</a></li><li><a class="nounderline abstract_t">Carlsen SE, Bergin CJ, Hoppe RT. MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning. AJR Am J Roentgenol 1993; 160:1191.</a></li><li><a class="nounderline abstract_t">Hoane BR, Shields AF, Porter BA, Borrow JW. Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging. Am J Hematol 1994; 47:100.</a></li><li><a class="nounderline abstract_t">Abdel Razek AA, Khairy M, Nada N. Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging. Radiology 2014; 273:268.</a></li><li><a class="nounderline abstract_t">Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254.</a></li><li><a class="nounderline abstract_t">Schwenzer NF, Schraml C, Müller M, et al. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. Radiology 2012; 264:551.</a></li><li><a class="nounderline abstract_t">Müller NL, Mayo JR, Zwirewich CV. Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT. AJR Am J Roentgenol 1992; 158:1205.</a></li><li><a class="nounderline abstract_t">Couch MJ, Ball IK, Li T, et al. Pulmonary ultrashort echo time 19F MR imaging with inhaled fluorinated gas mixtures in healthy volunteers: feasibility. Radiology 2013; 269:903.</a></li><li><a class="nounderline abstract_t">Gold GE, Pauly JM, Leung AN, et al. Short echo time MR spectroscopic imaging of the lung parenchyma. J Magn Reson Imaging 2002; 15:679.</a></li><li><a class="nounderline abstract_t">Benlala I, Berger P, Girodet PO, et al. Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease. Radiology 2019; 292:216.</a></li><li><a class="nounderline abstract_t">Biederer J. Using Lung MRI and Elastic Registration to Assess Pulmonary Fibrosis. Radiology 2019; 291:493.</a></li><li><a class="nounderline abstract_t">Fain SB, Korosec FR, Holmes JH, et al. Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 2007; 25:910.</a></li><li><a class="nounderline abstract_t">van Beek EJ, Wild JM. Hyperpolarized 3-helium magnetic resonance imaging to probe lung function. Proc Am Thorac Soc 2005; 2:528.</a></li><li><a class="nounderline abstract_t">Driehuys B, Martinez-Jimenez S, Cleveland ZI, et al. Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients. Radiology 2012; 262:279.</a></li><li><a class="nounderline abstract_t">Capaldi DP, Zha N, Guo F, et al. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps. Radiology 2016; 279:597.</a></li><li><a class="nounderline abstract_t">Niles DJ, Kruger SJ, Dardzinski BJ, et al. Exercise-induced bronchoconstriction: reproducibility of hyperpolarized 3He MR imaging. Radiology 2013; 266:618.</a></li><li><a class="nounderline abstract_t">Bolar DS, Levin DL, Hopkins SR, et al. Quantification of regional pulmonary blood flow using ASL-FAIRER. Magn Reson Med 2006; 55:1308.</a></li><li><a class="nounderline abstract_t">Rajaram S, Swift AJ, Capener D, et al. Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology 2012; 263:569.</a></li><li><a class="nounderline abstract_t">Wild JM, Marshall H, Xu X, et al. Simultaneous imaging of lung structure and function with triple-nuclear hybrid MR imaging. Radiology 2013; 267:251.</a></li><li><a class="nounderline abstract_t">Benlala I, Hocke F, Macey J, et al. Quantification of MRI T2-weighted High Signal Volume in Cystic Fibrosis: A Pilot Study. Radiology 2020; 294:186.</a></li><li><a class="nounderline abstract_t">Revel MP, Chassagnon G. Use of MRI to Measure Bronchial Inflammation in Cystic Fibrosis. Radiology 2020; 294:197.</a></li><li><a class="nounderline abstract_t">Dournes G, Berger P, Refait J, et al. Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis. Radiology 2017; 285:261.</a></li><li><a class="nounderline abstract_t">Vogel-Claussen J. Functional Lung MRI: Deep Learning Turns Proton into Helium Ventilation Maps-The Battle Is On! Radiology 2021; 298:439.</a></li><li><a class="nounderline abstract_t">Capaldi DPI, Guo F, Xing L, Parraga G. Pulmonary Ventilation Maps Generated with Free-breathing Proton MRI and a Deep Convolutional Neural Network. Radiology 2021; 298:427.</a></li><li class="breakAll">https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening (Accessed on September 04, 2017).</li><li><a class="nounderline abstract_t">Wang YX, Lo GG, Yuan J, et al. Magnetic resonance imaging for lung cancer screen. J Thorac Dis 2014; 6:1340.</a></li><li><a class="nounderline abstract_t">Burris NS, Johnson KM, Larson PE, et al. Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. Radiology 2016; 278:239.</a></li><li><a class="nounderline abstract_t">Mayr B, Lenhard M, Fink U, et al. Preoperative evaluation of bronchogenic carcinoma: value of MR in T- and N-staging. Eur J Radiol 1992; 14:245.</a></li><li><a class="nounderline abstract_t">Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705.</a></li><li><a class="nounderline abstract_t">Templeton PA, Caskey CI, Zerhouni EA. Current uses of CT and MR imaging in the staging of lung cancer. Radiol Clin North Am 1990; 28:631.</a></li><li><a class="nounderline abstract_t">Torigian DA, Zaidi H, Kwee TC, et al. PET/MR imaging: technical aspects and potential clinical applications. Radiology 2013; 267:26.</a></li><li><a class="nounderline abstract_t">Bruzzi JF, Komaki R, Walsh GL, et al. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics 2008; 28:551.</a></li><li><a class="nounderline abstract_t">Feneis J, Stark P. Pancoast Tumors: Persistent Diagnostic Challenge. Contemporary Diagnostic Radiology 2017; 40:1.</a></li><li><a class="nounderline abstract_t">Pichler BJ, Kolb A, Nägele T, Schlemmer HP. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 2010; 51:333.</a></li><li><a class="nounderline abstract_t">Ohno Y, Koyama H, Yoshikawa T, et al. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. Radiology 2015; 275:849.</a></li><li><a class="nounderline abstract_t">Chandarana H, Heacock L, Rakheja R, et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. Radiology 2013; 268:874.</a></li><li><a class="nounderline abstract_t">Krüger S, Haage P, Hoffmann R, et al. Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. Chest 2001; 120:1556.</a></li><li><a class="nounderline abstract_t">Finn JP, Baskaran V, Carr JC, et al. Thorax: low-dose contrast-enhanced three-dimensional MR angiography with subsecond temporal resolution--initial results. Radiology 2002; 224:896.</a></li><li><a class="nounderline abstract_t">Ingrisch M, Maxien D, Meinel FG, et al. Detection of pulmonary embolism with free-breathing dynamic contrast-enhanced MRI. J Magn Reson Imaging 2016; 43:887.</a></li><li><a class="nounderline abstract_t">Kalb B, Sharma P, Tigges S, et al. MR imaging of pulmonary embolism: diagnostic accuracy of contrast-enhanced 3D MR pulmonary angiography, contrast-enhanced low-flip angle 3D GRE, and nonenhanced free-induction FISP sequences. Radiology 2012; 263:271.</a></li><li><a class="nounderline abstract_t">van Beek EJ, Wild JM, Fink C, et al. MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003; 18:627.</a></li><li><a class="nounderline abstract_t">Ley S, Kreitner KF, Fink C, et al. Assessment of pulmonary hypertension by CT and MR imaging. Eur Radiol 2004; 14:359.</a></li><li><a class="nounderline abstract_t">Levin DL, Chen Q, Zhang M, et al. Evaluation of regional pulmonary perfusion using ultrafast magnetic resonance imaging. Magn Reson Med 2001; 46:166.</a></li><li><a class="nounderline abstract_t">Uematsu H, Levin DL, Hatabu H. Quantification of pulmonary perfusion with MR imaging: recent advances. Eur J Radiol 2001; 37:155.</a></li><li><a class="nounderline abstract_t">Mai VM, Liu B, Polzin JA, et al. Ventilation-perfusion ratio of signal intensity in human lung using oxygen-enhanced and arterial spin labeling techniques. Magn Reson Med 2002; 48:341.</a></li><li><a class="nounderline abstract_t">van der Meer RW, Lamb HJ, Smit JW, de Roos A. MR imaging evaluation of cardiovascular risk in metabolic syndrome. Radiology 2012; 264:21.</a></li><li><a class="nounderline abstract_t">Bamberg F, Kauczor HU, Weckbach S, et al. Whole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background. Radiology 2015; 277:206.</a></li><li><a class="nounderline abstract_t">Tong Y, Udupa JK, McDonough JM, et al. Quantitative Dynamic Thoracic MRI: Application to Thoracic Insufficiency Syndrome in Pediatric Patients. Radiology 2019; 292:206.</a></li></ol></div><div id="topicVersionRevision">Topic 6976 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22821695" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Molecular body imaging: MR imaging, CT, and US. Part II. Applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22623690" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Molecular body imaging: MR imaging, CT, and US. part I. principles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10855264" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Magnetic resonance imaging of the thorax. Past, present, and future.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12630683" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : MR angiography of the chest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26909650" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Impact of Nonvascular Thoracic MR Imaging on the Clinical Decision Making of Thoracic Surgeons: A 2-year Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28493800" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : IASLC/ITMIG Staging System and Lymph Node Map for Thymic Epithelial Neoplasms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8066274" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : MR imaging of chest wall lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8066273" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : CT and MR imaging evaluation of chest wall disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8451432" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32870136" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8305137" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Computed tomography (CT) and magnetic resonance imaging (MRI) of pleural masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9646980" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : CT and MR in pleural disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10988179" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : MRI and CT in the differential diagnosis of pleural disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1414807" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7953477" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : CT and MR imaging in the evaluation of pleural masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25310424" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2312846" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : MR imaging of pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32662762" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : MRI Assessment of Chylous and Nonchylous Effusions: Use of Multipoint Dixon Fat Quantification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22976916" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33001788" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Nontraumatic Chylothorax: Nonenhanced MR Lymphography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418317" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Magnetic resonance imaging of the mediastinum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7988271" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The role of CT and MRI in staging of the mediastinum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24361974" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A practical guide to nonvascular thoracic magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29528818" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Liver Iron Quantification with MR Imaging: A Primer for Radiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8498212" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8092123" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24877982" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10911007" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Preoperative staging of non-small-cell lung cancer with positron-emission tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22653189" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1590107" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23985278" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pulmonary ultrashort echo time 19F MR imaging with inhaled fluorinated gas mixtures in healthy volunteers: feasibility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12112518" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Short echo time MR spectroscopic imaging of the lung parenchyma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31161972" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30848699" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Using Lung MRI and Elastic Registration to Assess Pulmonary Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17410561" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Functional lung imaging using hyperpolarized gas MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16352759" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Hyperpolarized 3-helium magnetic resonance imaging to probe lung function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22056683" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26744928" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23169798" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Exercise-induced bronchoconstriction: reproducibility of hyperpolarized 3He MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16680681" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Quantification of regional pulmonary blood flow using ASL-FAIRER.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22396606" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23264344" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Simultaneous imaging of lung structure and function with triple-nuclear hybrid MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31660805" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Quantification of MRI T2-weighted High Signal Volume in Cystic Fibrosis: A Pilot Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31661364" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Use of MRI to Measure Bronchial Inflammation in Cystic Fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28530849" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33290176" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Functional Lung MRI: Deep Learning Turns Proton into Helium Ventilation Maps-The Battle Is On!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33289613" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pulmonary Ventilation Maps Generated with Free-breathing Proton MRI and a Deep Convolutional Neural Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33289613" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pulmonary Ventilation Maps Generated with Free-breathing Proton MRI and a Deep Convolutional Neural Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25276380" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Magnetic resonance imaging for lung cancer screen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26133050" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1563437" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Preoperative evaluation of bronchogenic carcinoma: value of MR in T- and N-staging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1847239" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2183267" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Current uses of CT and MR imaging in the staging of lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23525716" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : PET/MR imaging: technical aspects and potential clinical applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18349457" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pancoast Tumors: Persistent Diagnostic Challenge</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20150252" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : PET/MRI: paving the way for the next generation of clinical multimodality imaging applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25584709" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23737537" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11713134" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12202730" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Thorax: low-dose contrast-enhanced three-dimensional MR angiography with subsecond temporal resolution--initial results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26391931" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Detection of pulmonary embolism with free-breathing dynamic contrast-enhanced MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22438448" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : MR imaging of pulmonary embolism: diagnostic accuracy of contrast-enhanced 3D MR pulmonary angiography, contrast-enhanced low-flip angle 3D GRE, and nonenhanced free-induction FISP sequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14635147" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : MRI for the diagnosis of pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14740163" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Assessment of pulmonary hypertension by CT and MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11443723" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Evaluation of regional pulmonary perfusion using ultrafast magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11274843" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Quantification of pulmonary perfusion with MR imaging: recent advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12210943" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Ventilation-perfusion ratio of signal intensity in human lung using oxygen-enhanced and arterial spin labeling techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22723560" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : MR imaging evaluation of cardiovascular risk in metabolic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25989618" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Whole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31112090" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Quantitative Dynamic Thoracic MRI: Application to Thoracic Insufficiency Syndrome in Pediatric Patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
